Hayakawa, I., Takemura, M. & Kimura, Y. Recent progress in the studies of quinolone antibacterials. J. Synth. Org. Chem. Jpn. 52, 92–102 (1994).
Redgrave, L. S., Sutton, S. B., Webber, M. A. & Piddock, L. J. Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 22, 438–445 (2014).
De Oliveira, D. M. P. et al. Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 2020, 33 (2020).
Rice, L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J. Infect. Dis. 197, 1079–1081 (2008).
Fuzi, M., Bano, J. R. & Toth, A. Global evolution of pathogenic bacteria with extensive use of fluoroquinolone agents. Front. Microbiol. 11, 18 (2020).
Hiramatsu, K. et al. Multi-drug-resistant Staphylococcus aureus and future chemotherapy. J. Infect. Chemother. 20, 593–601 (2014).
Holmes, A. H. et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387, 176–187 (2016).
Harborne, J. B. & Williams, C. A. Flavone and flavonol glycosides. In The Flavonoids (eds Harborne, J. B. et al.) 376–441 (Springer, 1975).
Morimoto, Y., Baba, T., Sasaki, T. & Hiramatsu, K. Apigenin as an anti-quinolone-resistance antibiotic. Int. J. Antimicrob. Agents 46, 666–673 (2015).
Hiramatsu, K. et al. Curing bacteria of antibiotic resistance: Reverse antibiotics, a novel class of antibiotics in nature. Int. J. Antimicrob. Agents 39, 478–485 (2012).
Mierziak, J., Kostyn, K. & Kulma, A. Flavonoids as important molecules of plant interactions with the environment. Molecules 19, 16240–16265 (2014).
Fuzi, M., Szabo, D. & Csercsik, R. Double-serine fluoroquinolone resistance mutations advance major international clones and lineages of various multi-drug resistant bacteria. Front. Microbiol. 8, 14 (2017).
Adamczak, A., Ozarowski, M. & Karpinski, T. M. Antibacterial activity of some flavonoids and organic acids widely distributed in plants. J. Clin. Med. 9, 17 (2020).
Wang, S. et al. Bacteriostatic effect of quercetin as an antibiotic alternative in vivo and its antibacterial mechanism in vitro. J. Food Prot. 81, 68–78 (2018).
Jaisinghani, R. N. Antibacterial properties of quercetin. Microbiol. Res. 8, 1 (2017).
Siriwong, S., Thumanu, K., Hengpratom, T. & Eumkeb, G. Synergy and mode of action of ceftazidime plus quercetin or luteolin on Streptococcus pyogenes. Evid.-Based Complem. Altern. Med. 2015, 759459 (2015).
Li, K. et al. Anticomplement and antimicrobial activities of flavonoids from Entada phaseoloides. Nat. Prod. Commun. 7, 1934578X1200700715 (2012).
Liu, H. et al. Flavonoids from Halostachys caspica and their antimicrobial and antioxidant activities. Molecules 15, 7933–7945 (2010).
Basile, A., Giordano, S., López-Sáez, J. A. & Cobianchi, R. C. Antibacterial activity of pure flavonoids isolated from mosses. Phytochemistry 52, 1479–1482 (1999).
Basile, A. et al. Antibacterial and allelopathic activity of extract from Castanea sativa leaves. Fitoterapia 71, S110–S116 (2000).
Sato, Y. et al. Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 72, 483–488 (2000).
Cushnie, T. P. T. & Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26, 343–356 (2005).
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing M100. Assessed 03 Mar 2022 (2021).
Vipin, C., Mujeeburahiman, M., Ashwini, P., Arun, A. B. & Rekha, P. D. Anti-biofilm and cytoprotective activities of quercetin against Pseudomonas aeruginosa isolates. Lett. Appl. Microbiol. 68, 464–471 (2019).
Shu, Y. et al. Antibacterial activity of quercetin on oral infectious pathogens. Afr. J. Microbiol. Res. 5, 5358–5361 (2011).
Zeng, Y., Nikitkova, A., Abdelsalam, H., Li, J. & Xiao, J. Activity of quercetin and kaemferol against Streptococcus mutans biofilm. Arch. Oral Biol. 98, 9–16 (2019).
Nguyen, T. L. A. & Bhattacharya, D. Antimicrobial activity of quercetin: An approach to its mechanistic principle. Molecules 27, 2494 (2022).
Lynch, T. & Price, A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Phys. 76, 391–396 (2007).
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). In Vitro Drug Interaction Studies—Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry (2020).
von Moltke, L. L. et al. Inhibition of human cytochromes P450 by components of Ginkgo biloba. J. Pharm. Pharmacol. 56, 1039–1044 (2004).
Manach, C. et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett. 426, 331–336 (1998).
Yamamoto, N., Moon, J. H., Tsushida, T., Nagao, A. & Terao, J. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch. Biochem. Biophys. 372, 347–354 (1999).
Czeczot, H. et al. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res. 240, 209–216 (1990).
Resende, F. A., Vilegas, W., Dos Santos, L. C. & Varanda, E. A. Mutagenicity of flavonoids assayed by bacterial reverse mutation (Ames) test. Molecules 17, 5255–5268 (2012).
Rajhard, S. et al. Solubility of luteolin and other polyphenolic compounds in water, nonpolar, polar aprotic and protic solvents by applying FTIR/HPLC. Processes. 9, 1952 (2021).
Junior, S. et al. Antibacterial and antibiofilm activities of quercetin against clinical isolates of Staphyloccocus aureus and Staphylococcus saprophyticus with resistance profile. Int. J. Environ. Agric. Biotechnol. 3, 266213 (2018).
Lee, J.-H. et al. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect. Immun. 79, 4819–4827 (2011).
Cully, M. Public health: The politics of antibiotics. Nature 509, S16–S17 (2014).
Fukuda, H., Hori, S. & Hiramatsu, K. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob. Agents Chemother. 42, 1917–1922 (1998).
Morimoto, Y., Baba, T., Matsuda, M. & Hiramatsu, K. Nybomycin, a re-discovered “reverse antibiotic”, acts against quinolone resistant E. faecalis. Nippon Saikingaku Zasshi 72, 137 (2017).
Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 11th edn. (Clinical and Laboratory Standards Institute, 2018).
Matsuo, M. et al. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob. Agents Chemother. 55, 4188–4195 (2011).
Fisher, L. M. & Pan, X. S. Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities. Methods Mol. Med. 142, 11–23 (2008).
Akasaka, T., Tanaka, M., Yamaguchi, A. & Sato, K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: Role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob. Agents Chemother. 45, 2263–2268 (2001).
Onodera, Y., Okuda, J., Tanaka, M. & Sato, K. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis. Antimicrob. Agents Chemother. 46, 1800–1804 (2002).
Wickman, P. A., Black, J. A., Smith Moland, E., Thomson, K. S. & Hanson, N. D. In vitro development of resistance to DX-619 and other quinolones in enterococci. J. Antimicrob. Chemother. 58, 1268–1273 (2006).
Liu, Y. H. et al. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU. J. Microbiol. Immunol. Infect. 45, 108–112 (2012).
Li, B. et al. Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China. PLoS ONE 7, e42280 (2012).